News

The Unifill ready-to-fill (prefilled) syringe is a primary drug container with passive safety features fully integrated within the glass barrel. Under the agreement, Unilife has licensed Unifill syringe

O2h offers synthetic chemistry, FTE-based medicinal and process chemistry including in-vitro biology services to pharmaceutical and biotechnology companies. Heptares Chemistry head Miles Congreve said O2h has been a

Austria-based Vela offers research activities to clinical phases and up to product commercialization to its customers. VELA CEO Markus Fido said their customers will benefit from this alliance

Under the agreement, the US based pharma firm will evaluate GMP Cell lines of Roslin to assess specific clinical therapies’ potential. Further commercial terms of the agreement are

The first cohort of the SHIGATEC trial compares standard of care combined with a low dose of Shigamabs (1 mg/kg/dose) versus standard of care with placebo, in patients

With this acquisition, Teva will own around 550 products of Taiyo including all its local regulatory expertise and production facility in Japan. The acquisition also allows Teva to

Sucanon, an oral medication for type-2 diabetes, is a member of a class of diabetic medications called insulin sensitizers which help the body to make better usage of

Astellas has filed a notice of application to the Patented Medicine (Notice of Compliance) Regulations in Canada against Sandoz Canada related to the filing of an abbreviated new

The new facility will be made in 35000sqft area HCL’s Jurong Development Center in Singapore and is expected to be run under collaborations with educational and academic research